Cancer Research UK logo.
SearchDonate
  • Search

A trial of rituximab as an injection under the skin for diffuse large B cell lymphoma (MabEase)

Overview

Cancer types:

Blood cancers, Cell type, High grade lymphoma, Lymphoma, Non-Hodgkin lymphoma (NHL)

Status:

Results

Phase:

Phase 3

Details

This trial compared different ways of having rituximab alongside chemotherapy as the first treatment for diffuse large B cell lymphoma.

It was open for people to join between 2012 and 2016, and the research team published the results in 2017.

Recruitment start: 22 August 2012

Recruitment end: 18 September 2016

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Andrew Hodson

Supported by

NIHR Clinical Research Network: Cancer

Roche

Last reviewed: 28 September 2020

CRUK internal database number: 10669

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.